MTOR and melanoma: Following treatment with BA and BE, the expression levels of p-MAPK, p-PI3K, p-AKT, and p-mTOR exhibited a dose-dependent decrease, suggesting that regulation of autophagy-related pathways may represent a potential mechanism underlying the anti-melanoma effects of BA and BE.